Overview
Limited Cutaneous Systemic Sclerosis Plasma
Plasma samples from donors diagnosed with limited cutaneous systemic sclerosis (lcSSc) are collected and processed under rigorous standards. These samples support research into skin-limited fibrosis with vascular complications, offering insights into disease mechanisms, biomarker discovery, and therapeutic development.
Product Features
- Plasma isolated from clinically confirmed lcSSc donors
- Rigorous donor screening and sample quality checks
- Suitable for downstream applications such as flow cytometry, RNA-seq, ELISA, and qPCR
Donor Metadata
- Age, sex, race, medication, diagnosis method, disease severity/stage
- Optional: comorbidities, lab values, and clinical history
Applications
- Immunophenotyping
- Transcriptomics & proteomics
- Biomarker validation
- Therapeutic development and screening
Quality and Compliance
- IRB-approved protocols
- Informed donor consent
- Standardized collection and processing SOPs
Ordering & Shipping
Samples are available in both standard and custom volumes to meet your research needs.
International Orders: For international shipments or country-specific documentation requirements, please contact us at [email protected] to ensure compliance with your local regulations.
Protocols and Documentation
| Document Type | Technical Document |
|---|---|
| PDF > | Plasma Isolation |
Publications
Plasma Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.